1 – 27 of 27
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Autoimmune Disease in Turner Syndrome in Sweden : An up to 25 Years' Controlled Follow-up Study
(
- Contribution to journal › Article
-
Mark
Acromegaly management in the Nordic countries: A Delphi consensus survey
(
- Contribution to journal › Article
- 2023
-
Mark
Long-term Follow-up of 84 Patients With Giant Prolactinomas-A Swedish Nationwide Study
(
- Contribution to journal › Article
-
Mark
Reply to “Comment on aortic size predicts aortic dissection in Turner syndrome - A 25-year prospective cohort study” by Salman Khazaei
(
- Contribution to journal › Letter
-
Mark
Aortic size predicts aortic dissection in Turner syndrome - A 25-year prospective cohort study
(
- Contribution to journal › Article
- 2022
-
Mark
Increased Mortality Persists after Treatment of Cushing's Disease : A Matched Nationwide Cohort Study
(
- Contribution to journal › Article
-
Mark
Long-term outcomes of patients with acromegaly : a report from the Swedish Pituitary Register
(
- Contribution to journal › Article
-
Mark
Natural history and surgical outcome of Rathke's cleft cysts—A study from the Swedish Pituitary Registry
(
- Contribution to journal › Article
- 2021
-
Mark
Psychotropic Drugs in Patients with Cushing's Disease Before Diagnosis and at Long-Term Follow-Up : A Nationwide Study
(
- Contribution to journal › Article
-
Mark
Improved Urinary Cortisol Metabolome in Addison Disease : A Prospective Trial of Dual-Release Hydrocortisone
(
- Contribution to journal › Article
-
Mark
Prevalence of Nelson’s syndrome after bilateral adrenalectomy in patients with cushing’s disease : a systematic review and meta-analysis
(
- Contribution to journal › Article
-
Mark
Corticotroph Aggressive Pituitary Tumors and Carcinomas Frequently Harbor ATRX Mutations
(
- Contribution to journal › Article
- 2020
-
Mark
Real-world cost-effectiveness of insulin degludec in type 1 and type 2 diabetes mellitus from a Swedish 1-year and long-term perspective
(
- Contribution to journal › Article
-
Mark
Excess Morbidity Persists in Patients With Cushing's Disease During Long-term Remission : A Swedish Nationwide Study
(
- Contribution to journal › Article
- 2019
-
Mark
The incidence of Cushing’s disease : a nationwide Swedish study
(
- Contribution to journal › Article
-
Mark
Overall and Disease-Specific Mortality in Patients With Cushing Disease: A Swedish Nationwide Study
(
- Contribution to journal › Article
- 2017
-
Mark
Long-term safety of once-daily, dual-release hydrocortisone in patients with adrenal insufficiency : a phase 3b, open-label, extension study
(
- Contribution to journal › Article
- 2016
-
Mark
Limited value of cabergoline in Cushing's disease: a prospective study of a 6-week treatment in 20 patients.
(
- Contribution to journal › Article
- 2014
-
Mark
Prospective evaluation of long-term safety of dual-release hydrocortisone replacement administered once daily in patients with adrenal insufficiency.
(
- Contribution to journal › Article
- 2013
-
Mark
Hypothalamic Involvement Predicts Cognitive Performance and Psychosocial Health in Long-term Survivors of Childhood Craniopharyngioma
(
- Contribution to journal › Article
-
Mark
Psychosocial health and levels of employment in 851 hypopituitary Swedish patients on long-term GH therapy.
(
- Contribution to journal › Article
- 2011
-
Mark
Hypothalamic involvement and insufficient sex steroid supplementation are associated with low bone mineral density in women with childhood onset craniopharyngioma.
(
- Contribution to journal › Article
- 2010
-
Mark
Reduced Energy Expenditure and Impaired Feeding-Related Signals But Not High Energy Intake Reinforces Hypothalamic Obesity in Adults with Childhood Onset Craniopharyngioma.
(
- Contribution to journal › Article
- 2009
-
Mark
Hypothalamic involvement predicts cardiovascular risk in adults with childhood onset craniopharyngioma on long-term GH therapy.
(
- Contribution to journal › Article
-
Mark
Lipoatrophy in GH deficient patients treated with a long-acting pegylated GH
(
- Contribution to journal › Article
- 2007
-
Mark
Nonfatal stroke, cardiac disease, and diabetes mellitus in hypopituitary patients on hormone replacement including growth hormone
(
- Contribution to journal › Article
-
Mark
Fracture incidence in GH-deficient patients on complete hormone replacement including GH
(
- Contribution to journal › Article